Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE)  is pleased to announce that it has completed harvesting and drying its first two lots of cannabis at its Hamilton, Ontario facility; a process required by Health Canada prior to requesting a sales license. The Company will apply for a license to sell dried cannabis after it has received confirmation from a third-party laboratory that quality assurance testing results are compliant with the Access to Cannabis for Medical Purposes Regulations.

“We are extremely pleased with everything having gone according to what we expected. Furthermore, we have developed quite a bit of knowledge with respect to the strains we are cultivating, and are continually fine tuning our growing practices to optimize these strains for large scale commercial production,” commented Beleave CEO, Roger Ferreira. “Our facility is now in full production, with plants at each stage of the growth cycle. We anticipate a quick turnaround time between crops moving forward.”


About Beleave
Beleave Inc. is a biotech company and Beleave’s wholly-owned subsidiary Beleave Kannabis Corp. (formerly First Access Medical Inc.) is a licensed producer pursuant to the ACMPR. Beleave’s purpose-built facility is located near Hamilton, Ontario.

For further information please contact:

Sebastian de Kloet
Phone: (905) 979 – 5173
Email: sebastian@beleave.com
beleave.com

Forward-Looking Statements 

This news release contains “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). The use of any of the words “plan”, “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and other similar words, or statements that certain events or conditions “may” or “will” occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. These risks and uncertainties include, but are not limited to, the Company’s ability to satisfy the conditions associated with its cultivation licence, the Company’s ability to obtain a sales licence and the related timing considerations, the availability of further financing, consumer interest in its products, competition, regulation, operational and technological risks, and anticipated and unanticipated costs and delays. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com.

Click here to connect with Beleave Inc. (CNSX:BE) to receive an Investor Presentation

Source: globenewswire.com

The following issues have been halted by IIROC:

Company: Avicanna Inc.

Keep reading... Show less

Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market

PharmaCann is Well Positioned in Limited License States Across the Midwest and Northeast

Keep reading... Show less

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/

Avicanna Inc. (the “ Company ” or “ Avicanna ”) (TSX: AVCN) announced today that it has been issued a Cease Trade Order (“ CTO ”) by the Ontario Securities Commission (the “ OSC ”) as it no longer expects to file the following periodic disclosure documents (collectively, the “ Documents ”) by June 11, 2021, as previously disclosed:

Keep reading... Show less

Adds two accomplished female directors to the Board

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the results of its Annual and Special Meeting of Shareholders held on June 10, 2021 (the “Meeting”). Each of the eight individuals nominated for election as a director of Trulieve at the Meeting were elected, including new nominees, Giannella Alvarez and Jane Morreau .

Keep reading... Show less

The National Football League (NFL) wants to know more about cannabis as a pain reliever, and it’s willing to put up an initial US$1 million for research.

Also this week, a cannabis operator announced plans to buy assets from a languishing producer.

Keep reading... Show less